Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$7,351,662
+$482,458 QoQ
Shares Held
29,215
-7.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
#1,075
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SMITHBRIDGE ASSET MANAGEMENT INC/DE holds $39,618,201 across 7 Drug Manufacturers - General names. ABBV ranks #3 (18.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
43,597 | $11,072,330 | |
| 2 | NVS |
Novartis AG
|
49,133 | $7,700,123 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
29,215 | $7,351,662 | |
| 4 | LLY |
ELI LILLY & Co
|
5,883 | $7,056,247 | |
| 5 | NVO |
Novo Nordisk A S
|
102,069 | $4,893,187 | |
| 6 | MRK |
Merck & Co., Inc.
|
10,048 | $1,291,168 | |
| 7 | AMGN |
Amgen Inc
|
700 | $253,484 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,351,662 | 29,215 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $6,869,204 | 31,584 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $13,483,651 | 59,012 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $9,411,637 | 40,648 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $7,643,831 | 41,180 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $8,975,417 | 42,838 | Shares | Sole | 2025-04-16 | |
| 2024-09-30 | $8,835,452 | 44,741 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $7,625,436 | 44,458 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $8,574,360 | 47,086 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $7,511,240 | 48,469 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $7,317,951 | 49,094 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $6,704,030 | 49,759 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $7,917,660 | 49,681 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $8,071,449 | 49,944 | Shares | Sole | 2023-03-01 | |
| 2022-09-30 | $3,598,170 | 26,810 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $4,197,809 | 27,408 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $4,362,866 | 26,913 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $3,658,643 | 27,021 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $2,931,690 | 27,178 | Shares | Sole | 2021-10-04 | |
| 2021-06-30 | $3,032,381 | 26,921 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $2,862,851 | 26,454 | Shares | Sole | 2021-04-06 | |
| 2020-12-31 | $2,834,546 | 26,454 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $2,341,543 | 26,733 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $2,624,645 | 26,733 | Shares | Sole | 2020-07-01 | |
| 2020-03-31 | $2,059,644 | 27,033 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||